Article
Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies.
BMC nephrology - 6 Feb 2024
Li Ze, Wang Xiaozhen, Li Dandan, Cheng Sheng, Li Zhe, Guo Heng, Dong Yiwen, Zheng Yingming, Li Xingang
Abstract excerpt
PURPOSE: This study aimed to investigate the association between cytochrome P450 (CYP) 3A4*22 and cytochrome P450 oxidoreductase (POR)*28 variations and the pharmacokinetics of tacrolimus. METHODS: Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science (SCI), MEDLINE, and Embase were systematically searched from inception to August 2022. The outcomes were weight-adjusted daily dose and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
